Back to Search
Start Over
LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
- Source :
- Immuno-Oncology and Technology. 16:100360
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Immunology and Allergy
Subjects
Details
- ISSN :
- 25900188
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Immuno-Oncology and Technology
- Accession number :
- edsair.doi...........7abd92067fb63c206a7206d52807baad
- Full Text :
- https://doi.org/10.1016/j.iotech.2022.100360